Literature DB >> 16682687

Eyelid apraxia associated with subthalamic nucleus deep brain stimulation.

D C Shields1, S Lam, A Gorgulho, J Emerson, S E Krahl, D Malkasian, A A F DeSalles.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16682687     DOI: 10.1212/01.wnl.0000210693.13093.c8

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  6 in total

1.  Effects of varying subthalamic nucleus stimulation on apraxia of lid opening in Parkinson's disease.

Authors:  Giorgio Tommasi; Paul Krack; Valérie Fraix; Pierre Pollak
Journal:  J Neurol       Date:  2012-02-17       Impact factor: 4.849

2.  Periodic eyelid opening associated with burst-suppression electroencephalography due to hypoxic ischemic injury.

Authors:  Joseph M Ferrara; David J Houghton; Satish Rao
Journal:  Neurocrit Care       Date:  2012-12       Impact factor: 3.210

3.  Deep brain stimulation exacerbates hypokinetic dysarthria in a rat model of Parkinson's disease.

Authors:  Nathaniel O King; Collin J Anderson; Alan D Dorval
Journal:  J Neurosci Res       Date:  2015-10-26       Impact factor: 4.164

4.  Apraxia of Lid Opening in Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease-Frequency, Risk Factors and Response to Treatment.

Authors:  Syam Krishnan; Kuldeep Shetty; Divya Kalikavil Puthanveedu; Krishnakumar Kesavapisharady; Jissa Vinoda Thulaseedharan; Gangadhara Sarma; Asha Kishore
Journal:  Mov Disord Clin Pract       Date:  2021-04-12

5.  Delayed Onset Eye Opening Apraxia due to Progression of Brain Atrophy following Subthalamic Nucleus Deep Brain Stimulation: A Case Report.

Authors:  Takashi Morishita; Masa-Aki Higuchi; Yoshio Tsuboi; Kazuhiro Samura; Tooru Inoue
Journal:  NMC Case Rep J       Date:  2016-11-29

6.  Timing of deep brain stimulation in Parkinson disease: a need for reappraisal?

Authors:  Ruth-Mary deSouza; Elena Moro; Anthony E Lang; Anthony H V Schapira
Journal:  Ann Neurol       Date:  2013-05       Impact factor: 10.422

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.